Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olopatadine vs Epinastine for Allergic Conjunctivitis to Japanese Cedar Pollen
NCT02251613Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Dec 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of olopatadine in allergic conjunctivitis (AC), sponsored by Alcon Inc.. Started Dec 2013; status: completed.
02
Drugs
olopatadine
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT02251613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02251613.